Label with date, peptide name, and concentration
Exendin-4 Protects Endothelial Cells from Lipoapoptosis by PKA, PI3K, eNOS, P38 MAPK, and JNK Pathways
Cells were frozen as 1 mL aliquots containing 11.5 10 7 cells and separate aliquots were used for individual cAMP accumulation experiments
The groups were compared for body weight, fur condition, and walking status to confirm successful randomization
Patients on this protocol who also use metabolic support agents like Metformin should note that both agents activate AMPK, and physician oversight is warranted to avoid compounding effects on blood glucose that could theoretically cause hypoglycemia in susceptible individuals, though this has not been reported clinically with MOTS-c at standard doses